BR112015009395A2 - processo para preparação de derivados do ácido biliar - Google Patents
processo para preparação de derivados do ácido biliarInfo
- Publication number
- BR112015009395A2 BR112015009395A2 BR112015009395A BR112015009395A BR112015009395A2 BR 112015009395 A2 BR112015009395 A2 BR 112015009395A2 BR 112015009395 A BR112015009395 A BR 112015009395A BR 112015009395 A BR112015009395 A BR 112015009395A BR 112015009395 A2 BR112015009395 A2 BR 112015009395A2
- Authority
- BR
- Brazil
- Prior art keywords
- acid derivatives
- bile acid
- preparation
- preparing
- solvate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Abstract
resumo processo para preparação de derivados do ácido biliar a presente invenção refere-se a processos para a preparação de compostos da fórmula i: (i) ou de um sal ou um solvato farmaceuticamente aceitável do mesmo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261718966P | 2012-10-26 | 2012-10-26 | |
PCT/US2013/066917 WO2014066819A1 (en) | 2012-10-26 | 2013-10-25 | Process for preparing bile acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015009395A2 true BR112015009395A2 (pt) | 2017-07-04 |
Family
ID=50545344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015009395A BR112015009395A2 (pt) | 2012-10-26 | 2013-10-25 | processo para preparação de derivados do ácido biliar |
Country Status (21)
Country | Link |
---|---|
US (2) | US9777038B2 (pt) |
EP (1) | EP2912013B1 (pt) |
JP (1) | JP6272888B2 (pt) |
KR (1) | KR102068381B1 (pt) |
CN (2) | CN108250264A (pt) |
AU (1) | AU2013334122B2 (pt) |
BR (1) | BR112015009395A2 (pt) |
CA (1) | CA2889592A1 (pt) |
CY (1) | CY1119731T1 (pt) |
DK (1) | DK2912013T3 (pt) |
ES (1) | ES2655034T3 (pt) |
HK (2) | HK1253301A1 (pt) |
HU (1) | HUE036887T2 (pt) |
IL (1) | IL238454B (pt) |
MX (1) | MX361653B (pt) |
NO (1) | NO2968302T3 (pt) |
NZ (2) | NZ707389A (pt) |
PL (1) | PL2912013T3 (pt) |
PT (1) | PT2912013T (pt) |
SG (1) | SG11201503247UA (pt) |
WO (1) | WO2014066819A1 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201503247UA (en) | 2012-10-26 | 2015-06-29 | Intercept Pharmaceuticals Inc | Process for preparing bile acid derivatives |
EP3149019B1 (en) * | 2014-05-29 | 2019-12-04 | Bar Pharmaceuticals S.r.l. | Cholane derivatives for use in the treatment and/or prevention of fxr and tgr5/gpbar1 mediated diseases |
KR102526632B1 (ko) | 2014-11-19 | 2023-04-27 | 엔제트피 유케이 리미티드 | 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 5β-6-알킬-7-하이드록시-3-온 스테로이드 |
EP3221334B1 (en) | 2014-11-19 | 2020-02-19 | Nzp Uk Limited | 6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators |
CN107207559B (zh) | 2014-11-19 | 2019-10-25 | Nzp英国有限公司 | 作为制备类固醇fxr调节剂的中间体的6-烷基-7-羟基-4-烯-3-酮类固醇 |
TWI686401B (zh) | 2014-11-19 | 2020-03-01 | 英商Nzp英國有限公司 | 化合物(三) |
CN104672290B (zh) * | 2015-01-05 | 2017-06-06 | 北京普禄德医药科技有限公司 | 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途 |
CA2976056C (en) | 2015-02-06 | 2024-02-06 | Intercept Pharmaceuticals, Inc. | Pharmaceutical compositions for combination therapy |
AU2016325619A1 (en) * | 2015-09-24 | 2018-04-12 | Intercept Pharmaceuticals, Inc. | Methods and intermediates for the preparation bile acid derivatives |
AU2016350690C1 (en) * | 2015-11-06 | 2020-04-23 | Intercept Pharmaceuticals, Inc. | Methods for the preparation of obeticholic acid and derivatives thereof |
WO2017142895A1 (en) * | 2016-02-15 | 2017-08-24 | Regents Of The University Of Minnesota | Compositions and methods for treating clostridium associated diseases |
JP6968821B2 (ja) | 2016-04-13 | 2021-11-17 | インターセプト ファーマシューティカルズ, インコーポレイテッド | 癌を治療する方法 |
TW201738254A (zh) * | 2016-04-19 | 2017-11-01 | 英特賽普醫藥品公司 | 奧貝膽酸及其衍生物之製備方法 |
GB201608776D0 (en) | 2016-05-18 | 2016-06-29 | Dextra Lab Ltd | Methods and compounds |
GB201608777D0 (en) | 2016-05-18 | 2016-06-29 | Dextra Lab Ltd | Compounds |
KR20190057108A (ko) * | 2016-09-30 | 2019-05-27 | 인터셉트 파마슈티컬즈, 인크. | 담즙산 유도체의 결정형 |
MX2020000873A (es) | 2017-07-24 | 2020-07-22 | Intercept Pharmaceuticals Inc | Derivados de ácidos biliares marcados isotópicamente. |
JP7308811B2 (ja) | 2017-07-26 | 2023-07-14 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド | ステロイド系誘導体fxrアゴニストの製造方法 |
GB201812382D0 (en) | 2018-07-30 | 2018-09-12 | Nzp Uk Ltd | Compounds |
KR20220016146A (ko) | 2019-05-30 | 2022-02-08 | 인터셉트 파마슈티컬즈, 인크. | 담즙정체성 간 질환의 치료에서 사용하기 위한 fxr 효능제 및 피브레이트를 포함하는 제약 조성물 |
WO2021071837A1 (en) | 2019-10-07 | 2021-04-15 | Kallyope, Inc. | Gpr119 agonists |
JP2023526625A (ja) | 2020-05-19 | 2023-06-22 | キャリーオペ,インク. | Ampkアクチベーター |
CA3183575A1 (en) | 2020-06-26 | 2021-12-30 | Iyassu Sebhat | Ampk activators |
EP4215540A1 (en) | 2020-09-18 | 2023-07-26 | Seoul National University R & DB Foundation | Method for mass-producing sodium taurodeoxycholate |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5216015A (en) * | 1991-02-05 | 1993-06-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having hypocholesterolemic properties |
USRE48286E1 (en) * | 2001-03-12 | 2020-10-27 | Intercept Pharmaceuticals, Inc. | Steroids as agonists for FXR |
EP1568706A1 (en) | 2004-02-26 | 2005-08-31 | Intercept Pharmaceuticals, Inc. | Novel steroid agonist for FXR |
WO2008002573A2 (en) * | 2006-06-27 | 2008-01-03 | Intercept Pharmaceuticals, Inc. | Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions |
EP2303026B1 (en) * | 2008-06-17 | 2020-09-09 | Brigham Young University | Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods |
WO2010014836A2 (en) * | 2008-07-30 | 2010-02-04 | Intercept Pharmaceuticals, Inc. | Tgr5 modulators and methods of use thereof |
CN106380502A (zh) * | 2008-11-19 | 2017-02-08 | 英特塞普特医药品公司 | G蛋白偶联受体5(tgr5)调节剂及其使用方法 |
SG11201503247UA (en) | 2012-10-26 | 2015-06-29 | Intercept Pharmaceuticals Inc | Process for preparing bile acid derivatives |
-
2013
- 2013-10-25 SG SG11201503247UA patent/SG11201503247UA/en unknown
- 2013-10-25 US US14/438,323 patent/US9777038B2/en active Active
- 2013-10-25 EP EP13849263.2A patent/EP2912013B1/en active Active
- 2013-10-25 NZ NZ707389A patent/NZ707389A/en not_active IP Right Cessation
- 2013-10-25 JP JP2015539862A patent/JP6272888B2/ja not_active Expired - Fee Related
- 2013-10-25 ES ES13849263.2T patent/ES2655034T3/es active Active
- 2013-10-25 DK DK13849263.2T patent/DK2912013T3/en active
- 2013-10-25 AU AU2013334122A patent/AU2013334122B2/en not_active Ceased
- 2013-10-25 CN CN201810282054.XA patent/CN108250264A/zh active Pending
- 2013-10-25 CA CA2889592A patent/CA2889592A1/en not_active Abandoned
- 2013-10-25 BR BR112015009395A patent/BR112015009395A2/pt not_active Application Discontinuation
- 2013-10-25 PL PL13849263T patent/PL2912013T3/pl unknown
- 2013-10-25 PT PT138492632T patent/PT2912013T/pt unknown
- 2013-10-25 KR KR1020157012805A patent/KR102068381B1/ko active IP Right Grant
- 2013-10-25 HU HUE13849263A patent/HUE036887T2/hu unknown
- 2013-10-25 NZ NZ745013A patent/NZ745013A/en not_active IP Right Cessation
- 2013-10-25 MX MX2015005286A patent/MX361653B/es active IP Right Grant
- 2013-10-25 CN CN201380068062.XA patent/CN105102425B/zh not_active Expired - Fee Related
- 2013-10-25 WO PCT/US2013/066917 patent/WO2014066819A1/en active Application Filing
-
2014
- 2014-03-14 NO NO14725812A patent/NO2968302T3/no unknown
-
2015
- 2015-04-26 IL IL238454A patent/IL238454B/en active IP Right Grant
-
2016
- 2016-02-24 HK HK18112593.6A patent/HK1253301A1/zh unknown
- 2016-02-24 HK HK16102102.3A patent/HK1214239A1/zh not_active IP Right Cessation
-
2017
- 2017-08-21 US US15/681,609 patent/US10202414B2/en not_active Expired - Fee Related
-
2018
- 2018-01-03 CY CY20181100003T patent/CY1119731T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015009395A2 (pt) | processo para preparação de derivados do ácido biliar | |
PH12017501426A1 (en) | Derivatives of betulin | |
EA201592055A1 (ru) | 11-гидроксилпроизводные желчных кислот и их аминокислотные конъюгаты в качестве модуляторов фарнезоидных х-рецепторов | |
BR112013020996A2 (pt) | derivados aminobutíricos substituídos como inibidores de neprilisina | |
BR112015028452A2 (pt) | agonistas do receptor somastatina subtipo 4 (sstr4) | |
IN2014CN00989A (pt) | ||
NZ739760A (en) | Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same | |
EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
MX363127B (es) | Derivados de benzotiofeno como inhibidores del receptor de estrogeno. | |
WO2015010054A3 (en) | Neuroactive steroids, compositions, and uses thereof | |
MD20140063A2 (ro) | Derivaţi de acid benzotiazol-6-il acetic şi utilizarea acestora pentru tratarea unei infecţii HIV | |
UY34917A (es) | Inhibidores de la producción de leucotrieno-a4-hidrolasa (lta4h), composiciones farmacéuticas que los contienen y proceso para su preparación | |
BR112014003079A2 (pt) | derivado de 1,2,3,4-tetra-hidroquinolina útil para o tratamento de diabetes | |
BR112015004529A2 (pt) | alcóxi pirazóis como ativadores de guanilato ciclase solúvel | |
BR112015021240A2 (pt) | processo para sal de sódio de (2s, 5r)-2-carboxamido-7-oxo-6-sulfo-oxi-1,6-diaza-biciclo[3.2.1]octano | |
BR112018001869A2 (pt) | método para preparação de ácidos biliares e derivados dos mesmos | |
EA201491149A1 (ru) | Пиразолопиридиновые производные, способы их получения и их терапевтическое применение | |
BR112015010791A2 (pt) | moduladores de gpr40 de di-hidropirazol | |
BRPI1014802B8 (pt) | profármacos de triptolida. | |
EA201492023A1 (ru) | Регуляторы пути комплемента и их применение | |
BR112015010779A2 (pt) | moduladores de di-hidropirazol gpr40 | |
BR112013000254A2 (pt) | derivados heterocíclicos 1-fenil-substituídos e seu uso como moduladores do receptor de prostaglandina d2 | |
BR112014012459A2 (pt) | 2h-indazóis como antagonistas do receptor de ep2 | |
BR112014006559A2 (pt) | derivados do ácido betulínico com atividade antiviral | |
NI201200195A (es) | Procedimiento de preparación de la sal de l - arginina de perindoprilo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |